SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Chandra Shalabh

(Last) (First) (Middle)
C/O ANALOGIC CORPORATION
8 CENTENNIAL DRIVE

(Street)
PEABODY MA 01960

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/17/2015
3. Issuer Name and Ticker or Trading Symbol
ANALOGIC CORP [ ALOG ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 8,856 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) (1) 09/15/2018 Common Stock 1,960 $45.98 D
Non-Qualified Stock Option (right to buy) (2) 09/10/2019 Common Stock 2,650 $70.04 D
Non-Qualified Stock Option (right to buy) (3) 09/09/2020 Common Stock 3,759 $77.08 D
Non-Qualified Stock Option (right to buy) (4) 03/03/2021 Common Stock 372 $94.32 D
Non-Qualified Stock Option (right to buy) (5) 09/09/2021 Common Stock 5,099 $71.09 D
Restricted Stock Units (6) (6) Common Stock 2,345 $0.00 D
Restricted Stock Units (7) (7) Common Stock 2,195 $0.00 D
Restricted Stock Units (8) (8) Common Stock 219 $0.00 D
Restricted Stock Units (9) (9) Common Stock 3,020 $0.00 D
Restricted Stock Units (10) (10) Common Stock 1,000 $0.00 D
Explanation of Responses:
1. Represents options granted on 9/15/2011 which became exercisable on 9/15/2014.
2. Represents options granted on 9/10/2012, 1,325 of which became exercisable on 9/10/2014 and 1,325 of which will become exercisable on 9/10/2015.
3. The options are exercisable in three equal annual installments beginning 1 year after the grant date of 9/09/2013.
4. The options are exercisable in three equal annual installments beginning 1 year after the grant date of 3/03/2014.
5. The options will become exercisable in three equal annual installments beginning 1 year after the grant date of 9/09/2014.
6. The number of Restricted Stock Units ("RSUs)" represents the target number of RSUs that may be earned based on the achievement of certain performance criteria. The actual number of RSUs awarded may vary between 0 and twice the target, depending on the Company's performance. The performance period will end on July 31, 2015. As soon as reasonably practicable thereafter, a determination will be made as to whether and to what extent the performance criteria has been met. If such criteria has been met, the RSUs earned will be converted to common stock and a like number of shares will be issued to the grantee.
7. The number of RSUs represents the target number of RSUs that may be earned based on the achievement of certain performance criteria. The actual number of RSUs awarded may vary between 0 and twice the target, depending on the Company's performance. The performance period will end on July 31, 2016. As soon as reasonably practicable thereafter, a determination will be made as to whether and to what extent the performance criteria has been met. If such criteria has been met, the RSUs earned will be converted to common stock and a like number of shares will be issued to the grantee.
8. The number of RSUs represents the target number of RSUs that may be earned based on the achievement of certain performance criteria. The actual number of RSUs awarded may vary between 0 and twice the target, depending on the Company's performance. The performance period will end on July 31, 2016. As soon as reasonably practicable thereafter, a determination will be made as to whether and to what extent the performance criteria has been met. If such criteria has been met, the RSUs earned will be converted to common stock and a like number of shares will be issued to the grantee.
9. The number of RSUs represents the target number of RSUs that may be earned based on the achievement of certain performance criteria. The actual number of RSUs awarded may vary between 0 and twice the target, depending on the Company's performance. The performance period will end on July 31, 2017. As soon as reasonably practicable thereafter, a determination will be made as to whether and to what extent the performance criteria has been met. If such criteria has been met, the RSUs earned will be converted to common stock and a like number of shares will be issued to the grantee.
10. Represents RSUs granted on 9/16/2010 which will vest and be converted to common stock on 9/16/2015.
Remarks:
Sr VP & General Manager, Ultrasound Business
/s/ John J.Fry by Power of Attorney For: Shalabh Chandra 08/27/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.